• Mol Pharm. 2021;18:2263-2273. Abundance of P-glycoprotein and Breast Cancer Resistance Protein measured by targeted proteomics in human epileptogenic brain tissue. Brukner AM, Billington S, Benifla M, Nguyen TB, Han H, Bennett O, Gilboa T, Blatch D, Fellig Y, Volkov O, Unadkat JD, Ekstein D, Eyal S. PubMed
  • Front Pharmacol. 2018;9:1054.  Effects of Valproic Acid on cerebral nutrient carriers' expression in the rat. Mann Brukner A, Ben-Hur T, Honig A, Ekstein D, Eyal S. PubMed
  • Epilepsia. 2018;59:993-1003. Adverse placental effects of valproic acid: Studies in perfused human placentas. Rubinchik-Stern M, Shmuel M, Bar J, Kovo M, Eyal S. PubMed
  • Pharm Res. 2018;35:71. The placental barrier: the gate and the fate in drug distribution. Tetro N, Moushaev S, Rubinchik-Stern M, Eyal S. PubMed
  • J Control Release. 2017;257:2-9. Therapeutic efficacy of combined PEGylated liposomal doxorubicin and radiofrequency ablation: Comparing single and combined therapy in young and old mice. Andriyanov AV, Portnoy E, Koren E, Inesa S, Eyal S, Goldberg SN, Barenholz Y. PubMed
  • Surg Innov. 2017;24:139-144. Intraoperative localization of rectal tumors using liposomal Indocyanine Green. Magdassi S, Bar-David S, Friedman-Levi Y, Zigmond E, Varol C, Lahat G, Klausner J, Eyal S, Nizri E. PubMed
  • Front Pharmacol. 2016;7:426. Evaluation of Near Infrared dyes as markers of P-Glycoprotein activity in tumors. Semenenko I, Portnoy E, Aboukaoud M, Guzy S, Shmuel M, Itzhak G, Eyal S. PubMed
  • Clin Pharmacol Ther. 2016;100:479-488. Imaging transporters: Transforming diagnostic and therapeutic development. Mann A, Han H, Eyal S. PubMed
  • Mol Pharm. 2015;12:3351-7. Near infrared imaging of Indocyanine Green distribution in pregnant mice and effects of concomitant dedications. Bishara A, Meir M, Portnoy E, Shmuel M, Eyal S. PubMed
  • Epilepsia. 2015;56:1023-32. Antiepileptic drugs alter the expression of placental carriers: An in vitro study in a human placental cell line. Rubinchik-Stern M, Shmuel M, Eyal S. PubMed
  • AAPS J. 2015;17:788-801. Molecular imaging of membrane transporters' activity in cancer: a picture is worth a thousand tubes.Mann A, Semenenko I, Meir M, Eyal S. PubMed
  • J Nucl Med. 2014;55:1106-11. Activity of P-Glycoprotein, a β-Amyloid transporter at the Blood-Brain Barrier, is compromised in patients with mild Alzheimer disease. Deo AK, Borson S, Link JM, Domino K, Eary JF, Ke B, Richards TL, Mankoff DA, Minoshima S, O'Sullivan F, Eyal S, Hsiao P, Maravilla K, Unadkat JD. PubMed
  • Med Hypotheses. 2013;81:1059-62. The role of aquaporin-1 in idiopathic and drug-induced intracranial hypertension. Stiebel-Kalish H, Eyal S, Steiner I. PubMed
  • J Nucl Med. 2013;54:437-46. Modeling cyclosporine A inhibition of the distribution of a P-glycoprotein PET ligand, 11C-verapamil, into the maternal brain and fetal liver of the pregnant nonhuman primate: impact of tissue blood flow and site of inhibition. Ke AB, Eyal S, Chung FS, Link JM, Mankoff DA, Muzi M, Unadkat JD. PubMed
  • Mol Pharm. 2012;9:3595-601. Evaluation of the near infrared compound indocyanine green as a probe substrate of p-glycoprotein. Portnoy E, Gurina M, Magdassi S, Eyal S. PubMed
  • Front Pharmacol. 2012;3:126. Drug interactions at the human placenta: What is the evidence? Rubinchik-Stern M, Eyal S. PubMed
  • Clin Pharmacol Ther. 2010;87:579-85. Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography. Eyal S, Ke B, Muzi M, Link JM, Mankoff DA, Collier AC, Unadkat JD. PubMed
  • Drug Metab Dispos. 2010;38:833-40. Pharmacokinetics of metformin during pregnancy. Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD, Clark SM, Risler L, Wang J, Kelly EJ, Shen DD, Hebert MF. PubMed
  • Br J Pharmacol. 2010;159:394-404. Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate. Chung FS, Eyal S, Muzi M, Link JM, Mankoff DA, Kaddoumi A, O'Sullivan F, Hsiao P, Unadkat JD. PubMed
  • Mol Pharm. 2009;6:1883-90. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium. Swed A, Eyal S, Madar I, Zohar-Kontante H, Weiss L, Hoffman A. PubMed
  • J Nucl Med. 2009;50:798-806. Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primate. Eyal S, Chung FS, Muzi M, Link JM, Mankoff DA, Kaddoumi A, O'Sullivan F, Hebert MF, Unadkat JD. PubMed
  • Pharmacol Ther. 2009;123:80-104. Drug interactions at the blood-brain barrier: fact or fantasy? Eyal S, Hsiao P, Unadkat JD. PubMed
  • Br J Pharmacol. 2006;149:250-60. The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver. Eyal S, Lamb JG, Smith-Yockman M, Yagen B, Fibach E, Altschuler Y, White HS, Bialer M. PubMed


Jerusalem (Israel)


Last update: August 2021